Akzo Nobel N.V. Says Asenapine May Be Delayed, Shares Fall

AMSTERDAM, Oct 18 (Reuters) - Dutch chemicals group Akzo Nobel warned of a delay in launching its most promising pipeline drug asenapine and missed quarterly earnings expectations, sending its shares sliding on Wednesday.

>>> Discuss This Story

MORE ON THIS TOPIC